Abstract
Data modeling can be applied for improving precision of clinical studies. Multiple regression modeling is often used for that purpose. Relevant papers on this topic have recently been published (Breithaupt-Grogler et al. 1997; Debord et al. 1998; Kato et al. 1994; Mahmood and Mahayni 1999; Sabot et al. 1995; Ulrich et al. 2003; Vrecer et al. 2003). Although multiple regression modeling, generally, does not influence the magnitude of the treatment effect versus control, it may reduce overall variances in the treatment comparison and thus increase sensitivity or power of statistical testing. It tries to fit experimental data in a mathematical model, and, subsequently, tests how far distant the data are from the model. A statistically significant correlation indicates that the data are closer to the model than will happen with random sampling. The very model-principle is at the same time its largest limitation: biological processes are full of variations and will not allow for a perfect fit. In addition, the decision about the appropriate model is not well founded on statistical arguments. The current chapter assesses uncertainties and risks of misinterpretations commonly encountered with regression analyses and rarely communicated in research papers. Simple regression models and real data examples are used for assessment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antman EM, Cohen M, Bernink P, McGabe CH, Horacek T, Papuches G, Mautner B, Corbalan R, Radley D, Braunwald E (2000) The TIMI Risk score for unstable angina pectors, a method for prognostication and therapeutic decision making. J Am Med Assoc 284:835–842
Boeckman AJ, Sheiner LB, Beal SL (1992) NONMEM user’s guide. NONMEM Project Group, University California, San Francisco
Breithaupt-Grogler K, Maleczyk C, Belz GG, Butzer R, Herrman V, Stass H, Wensing G (1997) Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist – characterization by use of Schild regression techniques in man. Int J Clin Pharmacol Ther 35:434–441
Davidian M, Giltinan DM (1995) Nonlinear models for repeated measurements data. Chapman and Hall, New York
Debord J, Carpentier N, Sabot C, Bertin P, Marquet P, Treves R, Merle I, Lachatre G (1998) Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis. Int J Clin Pharmacol Ther 36:227–230
Hoetner G (2007) The use of logit and probit models in strategic management research. Strateg Manage J 28:331–343
Jukema JW, Bruschke AV, Van Boven AJ, Reiber JH, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, Van Rappard FM, Lie KI (1995) Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels (REGRESS Trial). Circulation 91:2528–2540
Kato Z, Fukutomi O, Yamazaki M, Kondo N, Imaeda N, Orii T (1994) Prediction of steady-state serum theophylline concentration in children by first-order and zero -order absorption models. Int J Clin Pharmacol Ther 32:231–234
Keusch P (2003) Chemical kinetics, rate laws, Arrhenius equation-experiments. http://www.uniregensburg.de/Fakultaeten/nat_Fak_IV/Organische_Chemie/Didaktik.html.
Lindstrom MJ, Bates BM (1990) Nonlinear mixed effects models for repeated measures data. Biometrics 46:673–678
Mahmood I, Mahayni H (1999) A limited sampling approach in bioequivalence studies: application to low half-life drugs and replicate design studies. Int J Clin Pharmacol Ther 37:275–281
Rudner LM (1998) Computer adaptive testing. http://edres.org/scripts/cat/catdemo.htm
Sabot C, Debord J, Roullet B, Marquet P, Merle L, Lachatre G (1995) Comparison of 2- and 3- compartment models for the Bayesian estimation of methotrexate pharmacokinetics. Int J Clin Pharmacol Ther 33:164–169
Ulrich S, Baumann B, Wolf R, Lehmann D, Peters B, Bogerts B (2003) Therapeutic drug monitoring of clozapine and relapse – a retrospective study of routine clinical data. Int J Clin Pharmacol Ther 41:3–13
Vrecer M, Turk S, Drinovec J, Mrhar A (2003) Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials. Int J Clin Pharmacol Ther 41:567–577
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Cleophas, T.J., Zwinderman, A.H. (2012). Logistic and Cox Regression, Markov Models, Laplace Transformations. In: Statistics Applied to Clinical Studies. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2863-9_17
Download citation
DOI: https://doi.org/10.1007/978-94-007-2863-9_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2862-2
Online ISBN: 978-94-007-2863-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)